Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX3 | P56373 | 2/20 | 0.64 |
| ▸ | P2RX4 | Q99571 | 2/20 | 0.64 |
| ▸ | P2RX2 | Q9UBL9 | 2/20 | 0.64 |
| ▸ | P2RY11 | Q96G91 | 2/20 | 0.64 |
| ▸ | P2RX6 | O15547 | 1/20 | 0.64 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.64 |
| ▸ | P2RX5 | Q93086 | 1/20 | 0.64 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.64 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.58 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.57 |
| ▸ | NT5E | P21589 | 1/20 | 0.53 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.52 |
| ▸ | GSK3A | P49840 | 2/20 | 0.51 |
| ▸ | RPS6KA3 | P51812 | 2/20 | 0.51 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22571193 | 0.94 | ENPP1 (0.66) | P2RX3P2RX4P2RX2P2RY11P2RX6 | |
| SCHEMBL5797749 | 0.86 | P2RX3 (0.66) | P2RX3P2RX4P2RX2P2RY11P2RX6 | |
| SCHEMBL13046091 | 0.86 | P2RX3 (0.66) | P2RX3P2RX4P2RX2P2RY11P2RX6 | |
| SCHEMBL5797743 | 0.86 | P2RX3 (0.66) | P2RX3P2RX4P2RX2P2RY11P2RX6 | |
| SCHEMBL23002345 | 0.84 | ADORA1 (0.57) | P2RY11ADORA1 | |
| SCHEMBL21374103 | 0.84 | ADORA1 (0.57) | P2RY11ADORA1 | |
| SCHEMBL14565268 | 0.84 | ADORA1 (0.57) | P2RY11ADORA1 | |
| SCHEMBL15293693 | 0.84 | ADORA1 (0.57) | P2RY11ADORA1 | |
| SCHEMBL13388121 | 0.84 | ADORA1 (0.57) | P2RY11ADORA1 | |
| SCHEMBL14384200 | 0.84 | ADORA1 (0.57) | P2RY11ADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11174279-B2 | Method for synthesizing ribonucleic acid H-phosphonate monomer, and oligonucleotide synthesis in which said monomer is used | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2021-11-16 | — | — | US | disclosed |
| US-20200331945-A1 | METHOD FOR SYNTHESIZING RIBONUCLEIC ACID H-PHOSPHONATE MONOMER, AND OLIGONUCLEOTIDE SYNTHESIS IN WHICH SAID MONOMER IS USED | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2020-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200331945-A1 | METHOD FOR SYNTHESIZING RIBONUCLEIC ACID H-PHOSPHONATE MONOMER, AND OLIGONUCLEOTIDE SYNTHESIS IN WHICH SAID MONOMER IS USED | RNGTT, RNASEL, NSUN3 | P2RX3 2126/4885P2RX4 2142/4885P2RX2 2237/4885 |
| US-11174279-B2 | Method for synthesizing ribonucleic acid H-phosphonate monomer, and oligonucleotide synthesis in which said monomer is used | RNGTT, RNASEL, NSUN3 | P2RX3 2126/4885P2RX4 2142/4885P2RX2 2237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.